Asset Management One’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,943
Closed -$147K 991
2025
Q1
$147K Hold
4,943
﹤0.01% 891
2024
Q4
$198K Hold
4,943
﹤0.01% 879
2024
Q3
$168K Sell
4,943
-2,075
-30% -$58.4K ﹤0.01% 892
2024
Q2
$152K Buy
7,018
+2,461
+54% +$51.7K ﹤0.01% 884
2024
Q1
$101K Buy
4,557
+2,244
+97% +$54.7K ﹤0.01% 916
2023
Q4
$66.2K Sell
2,313
-1,450
-39% -$35K ﹤0.01% 930
2023
Q3
$84K Buy
+3,763
New +$96.8K ﹤0.01% 935

Other funds holding VCYT

Asset Management One's VCYT Position: Q2 2025 in Review

Asset Management One sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 4,943 shares — an estimated $147K sold.

Asset Management One first reported a position in VCYT in Q3 2023 and held it in 7 quarters. The position peaked at $198K in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Asset Management One reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • Asset Management One sold 4,943 Veracyte shares in Q2 2025, an estimated $147K.
  • Asset Management One first reported a position in Veracyte in Q3 2023 and held it in 7 quarters.
  • Asset Management One's Veracyte position peaked at $198K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Asset Management One's 13F filing for Q2 2025, filed 31 Jul 2025.